Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

The First Affiliated Hospital With Nanjing Medical University

Clinical trials sponsored by The First Affiliated Hospital With Nanjing Medical University, explained in plain language.

Trials to join now! 45 Not yet recruiting 34 Not yet finished but already full! 6 Completed 10 Terminated 1

Experimental CAR T-Cell therapy targets two proteins to fight tough lymphoma

Disease control Terminated

This early-phase trial tested a new cell therapy called LUCAR-G39P in 11 patients with relapsed or refractory B-cell non-Hodgkin lymphoma. The therapy uses a patient's own immune cells, modified to attack two targets (CD19 and CD20) on cancer cells. The main goals were to check s…

Phase: PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC